Skip to content
10-Q

Quarterly Report

FUSE MEDICAL, INC. FZMD

0001564590-23-007256

← back to feed
Filed
May 15, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 12, 2023 73.9M sh
Shares Diluted Q1 2023 · Mar 31, 2023 70.32M sh
Shares Diluted Q1 2023 · Mar 31, 2022 70.32M sh
Operating Cash Flow Q1 2023 · Mar 31, 2023 $330.95K
Operating Cash Flow restated Q1 2023 · Mar 31, 2022 $494.14K
Stockholders Equity Q1 2023 · Mar 31, 2023 −$539.22K
Stockholders Equity Q1 2023 · Dec 31, 2022 −$310.85K
Stockholders Equity restated Q1 2023 · Mar 31, 2022 −$3.9M
Stockholders Equity Q1 2023 · Dec 31, 2021 −$3.43M
Current Liabilities Q1 2023 · Mar 31, 2023 $11.29M
Current Liabilities Q1 2023 · Dec 31, 2022 $12.39M
Total Liabilities Q1 2023 · Mar 31, 2023 $18.97M
Total Liabilities Q1 2023 · Dec 31, 2022 $20.07M
Current Assets Q1 2023 · Mar 31, 2023 $12.24M
Current Assets Q1 2023 · Dec 31, 2022 $13.77M
Total Assets Q1 2023 · Mar 31, 2023 $18.43M
Total Assets Q1 2023 · Dec 31, 2022 $19.76M
Eps Diluted Q1 2023 · Mar 31, 2023 $0.00
Eps Diluted Q1 2023 · Mar 31, 2022 −$0.01
Eps Basic Q1 2023 · Mar 31, 2023 $0.00
Eps Basic Q1 2023 · Mar 31, 2022 −$0.01
Sga Expense Q1 2023 · Mar 31, 2023 $1.71M
Sga Expense Q1 2023 · Mar 31, 2022 $1.71M
Net Income Q1 2023 · Mar 31, 2023 −$228.36K
Net Income restated Q1 2023 · Mar 31, 2022 −$476.4K
Operating Income Q1 2023 · Mar 31, 2023 −$165.58K
Operating Income restated Q1 2023 · Mar 31, 2022 −$438.59K
Gross Profit Q1 2023 · Mar 31, 2023 $2.82M
Gross Profit restated Q1 2023 · Mar 31, 2022 $2.81M
Cost Of Revenue Q1 2023 · Mar 31, 2023 $1.17M
Cost Of Revenue restated Q1 2023 · Mar 31, 2022 $1.74M
Revenue Q1 2023 · Mar 31, 2023 $3.98M
Revenue Q1 2023 · Mar 31, 2022 $4.55M